Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Clinical trial NCT04906395 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04906395
- Sponsor
- Tolmar Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2026-04-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.